Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2008-03-31

Original market date: See footnote 1

2008-03-31

Product name:

POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02269414

Product Monograph/Veterinary Labelling:

Date: 2018-12-10 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada  L5N 0C2

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

2

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

40:12.00   REPLACEMENT PREPARATIONS

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05BB01  ELECTROLYTES

Active ingredient group (AIG) number:See footnote 5

0213340004

List of active ingredient(s)
Active ingredient(s) Strength
POTASSIUM CHLORIDE 150 MG / 100 ML
SODIUM CHLORIDE 450 MG / 100 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: